Opinion Paper - Special Collection: UNAIDS Targets for 2030
Establishing targets for advanced HIV disease: A call to action
Submitted: 14 May 2021 | Published: 10 August 2021
About the author(s)
David B. Meya, Department of Research, Infectious Diseases Institute, Makerere University, Kampala, Uganda; and, Department of Medicine and International Health, University of Minnesota, Minneapolis, United States of AmericaLillian Tugume, Department of Research, Infectious Diseases Institute, Makerere University, Kampala, Uganda
Vennie Nabitaka, HIV Department, Clinton Health Access Initiative, Kampala, Uganda
Proscovia Namuwenge, Department of HIV Care and Treatment, Ministry of Health, Uganda, Kampala, Uganda
Sam Phiri, HIV Department, Lighthouse Trust Malawi, Lilongwe, Malawi
Rita Oladele, College of Medicine University of Lagos, Lagos, Nigeria
Bilkisu Jibrin, Department of HIV Care, Treatment and Support, Ministry of Health, Lagos, Nigeria
Mojisola Mobolaji-Bello, Department of HIV Care, Treatment and Support, Ministry of Health, Lagos, Nigeria
Cecilia Kanyama, Department of Medicine, University of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe, Malawi
Werner Maokola, National AIDS Control Program, Ministry of Health, Tanzania, Dar-es-Saalam, Tanzania
Sayoki Mfinanga, Department of Research, Muhimbili Medical Research Centre, Dar-es-Salaam, Tanzania
Cordelia Katureebe, Department of National HIV Care and Treatment, Ministry of Health, Kampala, Uganda
Ikechukwu Amamilo, Global Health Access Program, Clinton Health Access Initiative, Abuja, Nigeria
Brian Ngwatu, HIV Program, Clinton Health Access Initiative, Kampala, Uganda
Joseph N. Jarvis, Department of HIV, London School of Hygiene and Tropical Medicine, London, United Kingdom
Thomas S. Harrison, Centre for Global Health, Institute for Infection and Immunity, St. George’s University of London, London, United Kingdom
Amir Shroufi, Department of HIV, Centres for Disease Control Foundation, Atlanta, United States of America
Radha Rajasingham, Department of Medicine and International Health, University of Minnesota, Minneapolis, United States of America
David Boulware, Department of Medicine and International Health, University of Minnesota, Minneapolis, United States of America
Nelesh P. Govender, Department of Research, National Institute for Communicable Diseases, Johannesburg, South Africa
Angela Loyse, Department of Research, Centre for Global Health, Institute for Infection and Immunity, St. George’s University of London, London, United Kingdom
Abstract
Keywords
Metrics
Total abstract views: 4078Total article views: 4702
Crossref Citations
1. A cross-sectional study evaluating the screening, diagnosis and management of advanced HIV disease at the AIDS support organization service centre in Mbarara City, Southwestern Uganda
Paddy Mutungi Tukamuhebwa, Isla Gemmell
BMC Infectious Diseases vol: 25 issue: 1 year: 2025
doi: 10.1186/s12879-025-10682-3
2. Characteristics and clinical outcomes of patients presenting with advanced HIV disease in the “treat all” era: a retrospective cohort study from rural Rwanda
Gentille Musengimana, Jean Paul Umugisha, Placide Habinshuti, Todd Anderson, Geraldine Mukesharurema, Eric Remera, Jean D’Amour Ndahimana, Dale A. Barnhart
BMC Infectious Diseases vol: 22 issue: 1 year: 2022
doi: 10.1186/s12879-022-07692-w